Time-of-day variation in cardiovascular response to maximal exercise testing in coronary heart disease patients taking a beta-blocker

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 4, 2007, Pages 664-669

  Dufour Doiron, Monique ^a   Prud'homme, Denis ^b   Boulay, Pierre ^c  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Hopital Montfort Hospital   (Canada)

Author keywords

Atenolol; Beta adrenergic receptor blocker; Heart rate; Metoprolol; Rate pressure product

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; DRUG EFFECT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ATENOLOL; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; CORONARY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; METOPROLOL; MIDDLE AGED;

EID: 34848864627     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-047     Document Type: Article

References (25)

1. American College of Sports Medicine. 2005. ACSM's guidelines for exercise testing and prescription. 7th ed. Lippincott Williams & Wilkins, Baltimore, Md.
2. Augustin, C.-E. 1989. Cardiologie du praticien. 2nd ed. Presses de l'Université du Quebec, Qué.
3. Beta-Blocker Heart Attack Trial Research Group. 1982. A randomized trial of propranolol in patients with acute myocardial infarction. O. Mortality results. JAMA, 247: 1707-1714.
4. Eston, R., and Connolly, D. 1996. The use of ratings of perceived exertion for exercise prescription in patients receiving β-blocker therapy. Sports Med. 21: 176-190.
5. Fleg, J.L., Piña, I.L., Balady, G.J., Chaitman, B.R., Fletcher, B., Lavie, C., et al. 2000. Assessment of functional capacity in clinical and research applications: an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American Heart Association. Circulation, 102: 1591-1597.
6. Franklin, B.A., Gordon, S., and Timmis, G.C. 1996. Diurnal variation of ischemic response to exercise in patients receiving a once-daily dose of beta-blockers. Implications for exercise testing and prescription of exercise and training heart rates. Chest, 109: 253-257.
7. Franklin, B.A., Borysyk, L., Kornegger, G., Hollingsworth, V., Gordon, S., and Timmis, G.C. 1986. Variable responses to exercise testing in patients on "long-acting" beta-blockade: implications for exercise prescription. Med. Sci. Sports Exerc. 18: S68.
8. Gibbons, R.J., Balady, G.J., Bricker, T.J., Chaitman, B.R., Fletcher, G.F., Froelicher, V.F., et al. 2002. ACC/AHA 2002 Guideline Updated for Exercise Testing. Circulation, 106: 1883-1892. doi:10.1161/01.CIR.0000034670. 06526.15.
9. Gordon, N.F., and Duncan, J.J. 1991. Effect of beta-blockers on exercise physiology: implications for exercise training. Med. Sci. Sports Exerc. 23: 668-676.
10. Harrison. 1995. Médecine interne. 13th ed. McGraw-Hill Inc., New York.
11. Heart and Stroke Foundation of Canada. 1999. The changing face of heart disease and stroke in Canada 2000. Ottawa, Ont.
12. Heller, D.A., Ahern, F.M., and Kozak, M. 2000. Changes in rates of β-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction. Am. Heart J. 140: 663-671. doi:10.1067/mhj.2000. 109650.
13. Lee, T.H. 2000. Gaps in quality of cardiovascular care transcend social bias. Circulation, 102: 943-944.
14. López-Sendón, J., Swedberg, K., McMurray, J., Tamargo, J., Maggioni, A.P., Dargie, H., et al. 2004. Expert consensus document on β-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Societey of Cardiology. Eur. Heart J. 25: 1341-1362.
15. Marriott, J.D., Hartley, H., Sherwood, J., and Verity, L.S. 1992. Exercise heart rate during beta-blockade. J. Cardiopulm. Rehabil. 12: 202-207.
16. May, G.S., Eberlein, K.A., Furberg, C.D., Passamani, E.R., and DeMets, D.L. 1982. Secondary prevention after myocardial infarction: A review of long-term trials. Prog. Cardiovasc. Dis. 24: 331-352.
17. Morley, C.A., Cavalcanti, C., Perrins, E.J., and Sutton, R. 1983. A comparison of once daily atenolol and metoprolol in mild to moderate hypertension. Br. J. Clin. Pharmacol. 15: 715-717.
18. Nilsson, O.R., Atterhog, J.H., Castenfors, J., Jorfelt, L., and Karlberg, B.E. 1984. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives. Acta Med. Scand. 216: 301-307.
19. Opie, L.H., and Gersh, B.J. 2001. Drugs for the heart. 5th ed. Saunders Edition, Philadelphia.
20. Rathore, S.S., Berger, A.K., Weinfurt, D.P., Feinleib, M., Oetgen, W.J., Gersh, B.J., et al. 2000. Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation, 102: 642-648.
21. Samitz, -G. 1991. Aerobic training guidelines in beta-blocker therapy. An update. Wien. Med. Wochenschr. 141: 399-405.
22. Singh, B.N., Phil, D., and Venkatesh, N. 1984. Prevention of myocardial reinfarction and of sudden death in survivors of acute myocardial infarction: role of prophylactic β-adrenoceptor blockade. Am. Heart J. 107: 189-200. doi:10.1016/0002-8703(84)90165-0.
23. Speight, T.M., and Holford, N.H.G. 1997. Avery's drug treatment. 4th ed. Edition Adis International, Auckland, New Zealand.
24. Wilmore, J.H. 1988. Exercise testing, training, and beta-adrenergic blockade. Phys. Sportsmed. 16: 45-50.
25. Yusuf, S., Peto, R., Lewis, J., Collins, R., and Steight, P. 1985. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis. 27: 335-371.